ReP USP - Resultado da busca

Artigo de periodico
Macitentan Improves Health-Related Quality of Life for Patients With Pulmonary Arterial Hypertension: Results From the Randomized Controlled SERAPHIN Trial (2017)
Mehta, Sanjay; Sastry, Bhagavatula Kutumba Srinivasa; Souza, Rogério; Torbicki, Adam; Ghofrani, Hossein-Ardeschir; Channick, Richard N.; Delcroix, Marion; Pulido, Tomás; Simonneau, Gérald; Wlodarczyk, John; Rubin, Lewis J.; Jansa, Pavel; Hunsche, Elke; Galiè, Nazzareno; Perchenet, Loïc; Sitbon, Olivier
Fonte: CHEST. Unidade: FM
Assuntos: HIPERTENSÃO PULMONAR, QUALIDADE DE VIDA, FARMACOTERAPIA, FÁRMACOS DO SANGUE E SISTEMA HEMATOPOÉTICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MEHTA, Sanjay et al. Macitentan Improves Health-Related Quality of Life for Patients With Pulmonary Arterial Hypertension: Results From the Randomized Controlled SERAPHIN Trial. CHEST, v. 151, n. 1, p. 106-118, 2017Tradução . . Disponível em: https://doi.org/10.1016/j.chest.2016.08.1473. Acesso em: 23 out. 2025.
APA
Mehta, S., Sastry, B. K. S., Souza, R., Torbicki, A., Ghofrani, H. -A., Channick, R. N., et al. (2017). Macitentan Improves Health-Related Quality of Life for Patients With Pulmonary Arterial Hypertension: Results From the Randomized Controlled SERAPHIN Trial. CHEST, 151( 1), 106-118. doi:10.1016/j.chest.2016.08.1473
NLM
Mehta S, Sastry BKS, Souza R, Torbicki A, Ghofrani H-A, Channick RN, Delcroix M, Pulido T, Simonneau G, Wlodarczyk J, Rubin LJ, Jansa P, Hunsche E, Galiè N, Perchenet L, Sitbon O. Macitentan Improves Health-Related Quality of Life for Patients With Pulmonary Arterial Hypertension: Results From the Randomized Controlled SERAPHIN Trial [Internet]. CHEST. 2017 ; 151( 1): 106-118.[citado 2025 out. 23 ] Available from: https://doi.org/10.1016/j.chest.2016.08.1473
Vancouver
Mehta S, Sastry BKS, Souza R, Torbicki A, Ghofrani H-A, Channick RN, Delcroix M, Pulido T, Simonneau G, Wlodarczyk J, Rubin LJ, Jansa P, Hunsche E, Galiè N, Perchenet L, Sitbon O. Macitentan Improves Health-Related Quality of Life for Patients With Pulmonary Arterial Hypertension: Results From the Randomized Controlled SERAPHIN Trial [Internet]. CHEST. 2017 ; 151( 1): 106-118.[citado 2025 out. 23 ] Available from: https://doi.org/10.1016/j.chest.2016.08.1473
Artigo de periodico
Incident and prevalent cohorts with pulmonary arterial hypertension: insight from SERAPHIN (2015)
Simonneau, Gérald; Channick, Richard N.; Delcroix, Marion; Galiè, Nazzareno; Ghofrani, Hossein-Ardeschir; Jansa, Pavel; Le Brun, Franck-Olivier; Mehta, Sanjay; Perchenet, Loic; Pulido, Tomás; Sastry, B. K. S.; Sitbon, Olivier; Souza, Rogério; Torbicki, Adam; Rubin, Lewis J.
Fonte: European respiratory journal. Unidade: FM
Assuntos: HIPERTENSÃO PULMONAR, ESTUDOS DE COORTES, FÁRMACOS (SISTEMA RESPIRATÓRIO), ESTUDOS RANDOMIZADOS, HIPERTENSÃO PULMONAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SIMONNEAU, Gérald et al. Incident and prevalent cohorts with pulmonary arterial hypertension: insight from SERAPHIN. European respiratory journal, v. 46, n. 6, p. 1711-1720, 2015Tradução . . Disponível em: https://doi.org/10.1183/13993003.00364-2015. Acesso em: 23 out. 2025.
APA
Simonneau, G., Channick, R. N., Delcroix, M., Galiè, N., Ghofrani, H. -A., Jansa, P., et al. (2015). Incident and prevalent cohorts with pulmonary arterial hypertension: insight from SERAPHIN. European respiratory journal, 46( 6), 1711-1720. doi:10.1183/13993003.00364-2015
NLM
Simonneau G, Channick RN, Delcroix M, Galiè N, Ghofrani H-A, Jansa P, Le Brun F-O, Mehta S, Perchenet L, Pulido T, Sastry BKS, Sitbon O, Souza R, Torbicki A, Rubin LJ. Incident and prevalent cohorts with pulmonary arterial hypertension: insight from SERAPHIN [Internet]. European respiratory journal. 2015 ; 46( 6): 1711-1720.[citado 2025 out. 23 ] Available from: https://doi.org/10.1183/13993003.00364-2015
Vancouver
Simonneau G, Channick RN, Delcroix M, Galiè N, Ghofrani H-A, Jansa P, Le Brun F-O, Mehta S, Perchenet L, Pulido T, Sastry BKS, Sitbon O, Souza R, Torbicki A, Rubin LJ. Incident and prevalent cohorts with pulmonary arterial hypertension: insight from SERAPHIN [Internet]. European respiratory journal. 2015 ; 46( 6): 1711-1720.[citado 2025 out. 23 ] Available from: https://doi.org/10.1183/13993003.00364-2015
Artigo de periodico
Effect of macitentan on hospitalizations: Results from the SERAPHIN trial (2015)
Channick, Richard N.; Delcroix, Marion; Ghofrani, Hossein-Ardeschir; Hunsche, Elke; Jansa, Pavel; Le Brun, Franck-Olivier; Mehta, Sanjay; Pulido, Tomás; Rubin, Lewis J.; Sastry, B. K. S.; Simonneau, Gérald; Sitbon, Olivier; Souza, Rogério de; Torbicki, Adam; Galiè, Nazzareno
Fonte: JACC Heart failure. Unidade: FM
Assuntos: HIPERTENSÃO PULMONAR, FÁRMACOS/SISTEMA RESPIRATÓRIO, HOSPITALIZAÇÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CHANNICK, Richard N. et al. Effect of macitentan on hospitalizations: Results from the SERAPHIN trial. JACC Heart failure, v. 3, n. 1, p. 1-8, 2015Tradução . . Disponível em: https://doi.org/10.1016/j.jchf.2014.07.013. Acesso em: 23 out. 2025.
APA
Channick, R. N., Delcroix, M., Ghofrani, H. -A., Hunsche, E., Jansa, P., Le Brun, F. -O., et al. (2015). Effect of macitentan on hospitalizations: Results from the SERAPHIN trial. JACC Heart failure, 3( 1), 1-8. doi:10.1016/j.jchf.2014.07.013
NLM
Channick RN, Delcroix M, Ghofrani H-A, Hunsche E, Jansa P, Le Brun F-O, Mehta S, Pulido T, Rubin LJ, Sastry BKS, Simonneau G, Sitbon O, Souza R de, Torbicki A, Galiè N. Effect of macitentan on hospitalizations: Results from the SERAPHIN trial [Internet]. JACC Heart failure. 2015 ; 3( 1): 1-8.[citado 2025 out. 23 ] Available from: https://doi.org/10.1016/j.jchf.2014.07.013
Vancouver
Channick RN, Delcroix M, Ghofrani H-A, Hunsche E, Jansa P, Le Brun F-O, Mehta S, Pulido T, Rubin LJ, Sastry BKS, Simonneau G, Sitbon O, Souza R de, Torbicki A, Galiè N. Effect of macitentan on hospitalizations: Results from the SERAPHIN trial [Internet]. JACC Heart failure. 2015 ; 3( 1): 1-8.[citado 2025 out. 23 ] Available from: https://doi.org/10.1016/j.jchf.2014.07.013

Unidades USP

ReP

Filtros

Autores

Assuntos

Afiliação dos autores externos não normalizada

País das instituições de afiliação dos autores externos